Outcomes of Adding Induction Chemotherapy to Concurrent Chemotherapy for Nasopharyngeal Carcinoma Patients with Moderate-Risk in the Intensity-Modulated Radiotherapy Era

Zhen Su1 Panyu Central Hospital, Cancer Institute of Panyu, Guangzhou, People’s Republic of ChinaView further author information

Guo-rong Zou1 Panyu Central Hospital, Cancer Institute of Panyu, Guangzhou, People’s Republic of ChinaView further author information

Jie Tang1 Panyu Central Hospital, Cancer Institute of Panyu, Guangzhou, People’s Republic of ChinaView further author information

Xiu Yue Li1 Panyu Central Hospital, Cancer Institute of Panyu, Guangzhou, People’s Republic of ChinaView further author information

Fang-Yun Xie2 Department of Radiation Oncology, Sun Yat-Sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou510060, People’s Republic of ChinaCorrespondence[email protected]
View further author information

Citations (2)

Keep up to date with the latest research on this topic with citation updates for this article.

Outcomes of Adding Induction Chemotherapy to Concurrent Chemotherapy for Nasopharyngeal Carcinoma Patients with Moderate-Risk in the Intensity-Modulated Radiotherapy Era

Articles from other publishers (2)

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Outcomes of Adding Induction Chemotherapy to Concurrent Chemotherapy for Nasopharyngeal Carcinoma Patients with Moderate-Risk in the Intensity-Modulated Radiotherapy Era

Citations (2)

Articles from other publishers (2)

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date